#news #biotech Metabolic biotech Metacrine gains $22M for NASH tests

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Metabolic biotech Metacrine gains $22M for NASH tests .We’ve spoken a lot about NASH this week, this year in fact, but Metacrine is seeing us talk about it again after getting off a series B as it aims to combat the fatty liver disorder.

from FierceBiotech: Biotech http://ift.tt/2AiUUK6